One-year outcomes of a digital twin intervention for type 2 diabetes: a retrospective real-world study.

Paramesh Shamanna¹, Ravi Sankar Erukulapati², Ashutosh Shukla³, Lisa Shah⁴, Bree Willis⁴, Mohamed Thajudeen⁵, Rajiv Kovil⁶, Rahul Baxi⁷, Mohsin Wali⁸, Suresh Damodharan⁹, Shashank Joshi¹⁰

¹Bangalore Diabetes Centre, Bangalore, Karnataka, 560043, India. drparamesh2@gmail.com.

²Apollo Hospital, Jubilee Hills, Hyderabad, India.

³Max Hospital & Prana Centre of Integrative Medicine, Gurgaon, Haryana, India.

⁴Twin Health, Mountain View, CA, USA.

⁵Twin Health, Mohamed Thajudeen, Research Doctor, Chennai, India.

⁶Dr. Kovil's Diabetes Care Centre, Mumbai, Maharashtra, India.

⁷Bombay Hospital and Medical Research Centre, Mumbai, India.

⁸Sir Ganga Ram Hospital, New Delhi, Delhi, India.

⁹Hospital and Harvey Speciality Clinic, Coimbatore, India.

¹⁰Department of Diabetology and Endocrinology, Lilavati Hospital and Research center, Mumbai, India.

PubMed PMC DOI PDF

Abstract

This retrospective observational study, building on prior research that demonstrated the efficacy of the Digital Twin (DT) Precision Treatment Program over shorter follow-up periods, aimed to examine glycemic control and reduced anti-diabetic medication use after one-year in a DT commercial program. T2D patients enrolled had adequate hepatic and renal function and no recent cardiovascular events…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.